Journal Mobile Options
Table of Contents
Vol. 119, No. 1, 2011
Issue release date: August 2011
Cardiology 2011;119:1–6

Bromocriptine-Induced Coronary Spasm Caused Acute Coronary Syndrome, Which Triggered Its Own Clinical Twin – Takotsubo Syndrome

Y-Hassan S. · Jernberg T.
Department of Cardiology, Karolinska University Hospital, Huddinge, Stockholm, Sweden

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Bromocriptine-induced coronary spasm (BICS) causing myocardial infarction has been reported. Association between BICS and Takotsubo syndrome (TS) has not been described. We report on a 37-year-old woman presenting with a clinical picture of acute coronary syndrome 1 day after initiation of treatment with bromocriptine for ablactation 3 weeks after a full-term spontaneous vaginal delivery. Coronary angiography showed diffuse narrowing of a large diagonal branch. Left ventriculography showed widespread hypokinesia extending beyond the diagonal branch supply region. There was a slight elevation of myocardial infarction biomarkers that was disproportional to the degree of left ventricular dysfunction. Follow-up coronary angiography, intravascular ultrasound and left ventriculography showed normal coronary arteries including the diagonal branch and complete normalization of the left ventricular function. Cardiac magnetic resonance examination showed no signs of late myocardial gadolinium enhancement. The clinical picture and course of the disease was consistent with TS. Consequently, we describe for the first time a case of TS triggered by myocardial ischemia caused by BICS. Furthermore, our case and sufficient supporting data from the literature demonstrate that acute coronary syndrome is an important and frequent but up till now missed trigger factor for TS.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Ruch A, Duhring JL: Postpartum myocardial infarction in a patient receiving bromocriptine. Obstet Gynecol 1989;74:448–451.
  2. Iffy L, Lindenthal J, Mcardle JJ, Ganesh V: Severe cerebral accidents postpartum in patients taking bromocriptine for milk suppression. Isr J Med Sci 1996;32:309–312.
  3. Hopp L, Weisse AB, Iffy L: Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression. Can J Cardiol 1996;12:415–418.
  4. Hara M, Takakura T, Nanimatsu K, Maeda T, Nakagawa M, Tamura M, Koumatsu K, Inoue K, Saikawa T, Ito S: Acute myocardial infarction probably induced by the oral administration of bromocriptine: a case report. J Cardiol 1989;19:609–614.
  5. Eickman FM: Recurrent myocardial infarction in a postpartum patient receiving bromocriptine. Clin Cardiol 1992;15:781–783.
  6. Lopez PR, Peiris AN: Kounis syndrome. South Med J 2010;103:1148–1155.

    External Resources

  7. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E: Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006;27:1523–1529.
  8. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ: Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010;55:333–341.

    External Resources

  9. Mansencal N, Abbou N, Pilliére R, El Mahmoud R, Farcot JC, Dubourg O: Usefulness of two-dimensional speckle tracking echocardiography for assessment of Tako-Tsubo cardiomyopathy. Am J Cardiol 2009;103:1020–1024.

    External Resources

  10. Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A: Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol 1994;24:636–640.
  11. Win CH, Panthac A, Guglin M: Not Takotsubo: a different form of stress-induced cardiomyopathy – a case series. Congest Heart Fail 2011;17:38–41.

    External Resources

  12. Prasad A, Lerman A, Rihal CS: Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008;155:408–417.
  13. Winchester DE, Ragosta M, Taylor AM: Concurrence of angiographic coronary artery disease in patients with apical ballooning syndrome (Tako-Tsubo cardiomyopathy). Catheter Cardiovasc Interv 2008;72:612–616.

    External Resources

  14. Gaibazzi N, Ugo F, Vignali L, Zoni A, Reverberi C, Gherli T: Tako-Tsubo cardiomyopathy with coronary artery stenosis: a case-series challenging the original definition. Int J Cardiol 2009;133:205–212.
  15. Y-Hassan S, Sylvén C, Tornvall P: Takotsubosyndrom möjligt även vid obstruktiv kranskärlssjukdom. Läkartidningen 2011;108:864–867.
  16. Nojima Y, Kotani J: Global coronary artery spasm caused Takotsubo cardiomyopathy. J Am Coll Cardiol 2010;55:e17.

    External Resources

  17. Gurlek C, van Es J, van der Burgh PH, Galjee MA, von Birgelen C: Full pattern of transient apical ballooning of the left ventricle triggered by minor myocardial infarction. Neth Heart J 2007;15:310–311.
  18. Koeth O, Zeymer U, Schiele R, Zahn R: Inferior ST-elevation myocardial infarction associated with Takotsubo cardiomyopathy. Case Report Med 2010; pii:467867.
  19. Braunwald E, Kloner R: The sunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146–1149.
  20. Kloner RA, Arimie RB, Kay GL, Cannom D, Matthews R, Bhandari A, Shook T, Pollick C, Burstein S: Evidence for stunned myocardium in humans: a 2001 update. Coron Artery Dis 2001;12:349–356.
  21. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M: Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 1991;21:203–214.
  22. Chao T, Lindsay J, Collins S, Woldeyes L, Joshi SB, Steinberg DH, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R: Can acute occlusion of the left anterior descending coronary artery produce a typical ‘Takotsubo’ left ventricular contraction pattern? Am J Cardiol 2009;104:202–204.
  23. Lindsay J, Paixao A, Chao T, Pichard AD: Pathogenesis of the Takotsubo syndrome: a unifying hypothesis. Am J Cardiol 2010;106:1360–1363.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50